Oxidized Cellulose hEmostAsis evaluatioN
- Conditions
- Intra-operative Bleeding
- Registration Number
- NCT01637025
- Lead Sponsor
- Baxter Healthcare Corporation
- Brief Summary
The purpose of this study is to evaluate the safety and effectiveness of Traumastem to help stop bleeding in participants undergoing open cardiac, intra-abdominal (including retroperitoneal) and pelvic surgery as compared to Surgicel® Original (Surgicel; in some countries marketed as Tabotamp®)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 111
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Occurrence of adverse events (AEs)/ adverse device effects (ADEs) ≤30 ± 5 days/ end-of-study visit after device application Occurrence of adverse events (AEs)/ adverse device effects (ADEs) up to 30 ± 5 days/ end-of-study visit after device application.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (23)
Chirurgicke oddeleni Nemocnice Liberec
🇨🇿Liberec, Czech Republic
Kardiochirurgicke oddeleni FN Plzen
🇨🇿Plzen - Lochotin, Czech Republic
Chirurgicka klinika FN KV
🇨🇿Praha, Czech Republic
Chirurgicka klinika UVN
🇨🇿Praha, Czech Republic
Chirurgicke oddeleni Fakultni nemocnice Na Bulovce
🇨🇿Praha, Czech Republic
Kardiochirurgicka klinika FN KV
🇨🇿Praha, Czech Republic
Klinika kardiovaskularni chirurgie IKEM
🇨🇿Praha, Czech Republic
Klinik für Allgemein-, Visceral- und Transplantationschirurgie Charité Berlin
🇩🇪Berlin, Germany
Klinik für Allgemein-, Visceral-, Gefäß- und Thoraxchirurguie Charité Universitätsmedizin Berlin - Campus Mitte
🇩🇪Berlin, Germany
Allgemein- und Viszeralchirurgie Johann Wolfgang Goethe Universitätsklinikum
🇩🇪Frankfurt am Main, Germany
Scroll for more (13 remaining)Chirurgicke oddeleni Nemocnice Liberec🇨🇿Liberec, Czech Republic